Discovery and Pre-Clinical Characterization of Third-Generation 4-H Heteroaryldihydropyrimidine (HAP) Analogues as Hepatitis B Virus (HBV) Capsid Inhibitors
Authors:
- 5 April 2017
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 60 (8) , 3352-3371
Abstract
Described herein are the discovery and structure–activity relationship (SAR) studies of the third-generation 4-H heteroaryldihydropyrimidines (4-H HAPs) featuring the introduction of a C6 carboxyl group as novel HBV capsid inhibitors. This new series of 4-H HAPs showed improved anti-HBV activity and better drug-like properties compared to the first- and second-generation 4-H HAPs. X-ray crystallographic study of analogue 12 (HAP_R01) with Cp149 Y132A mutant hexamer clearly elucidated the role of C6 carboxyl group played for the increased binding affinity, which formed strong hydrogen bonding interactions with capsid protein and coordinated waters. The representative analogue 10 (HAP_R10) was extensively characterized in vitro (ADMET) and in vivo (mouse PK and PD) and subsequently selected for further development as oral anti-HBV infection agent.Keywords
This publication has 28 references indexed in Scilit:
- Novel targets for hepatitis B virus therapyLiver International, 2017
- The current status and future directions of hepatitis B antiviral drug discoveryExpert Opinion on Drug Discovery, 2016
- Novel Therapeutics in Discovery and Development for Treatment of Chronic HBV Infection2013
- Assembly-Directed Antivirals Differentially Bind Quasiequivalent Pockets to Modify Hepatitis B Virus Capsid Tertiary and Quaternary StructureStructure, 2013
- Sulfamoylbenzamide Derivatives Inhibit the Assembly of Hepatitis B Virus NucleocapsidsJournal of Virology, 2013
- EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infectionJournal of Hepatology, 2012
- Trapping of Hepatitis B Virus Capsid Assembly Intermediates by Phenylpropenamide Assembly AcceleratorsACS Chemical Biology, 2010
- Small-Molecule Effectors of Hepatitis B Virus Capsid Assembly Give Insight into Virus Life CycleJournal of Virology, 2008
- Inhibition of Hepatitis B Virus Replication by Drug-Induced Depletion of NucleocapsidsScience, 2003
- Phenylpropenamide derivatives as inhibitors of Hepatitis B virus replicationBioorganic & Medicinal Chemistry Letters, 2000